BioStratum develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Durham
State: North Carolina
Zip:
Country: United States
BioStratum, Inc. develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications. Its products include Pyridorin, a small molecule drug for the treatment of diabetic kidney disease; and pre-clinical compounds that treat diabetic complications and cancer. The company was founded in 1994 and is headquartered in Durham, North Carolina.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2007 | NephroGenex | Series A | 0 |
7/2007 | NephroGenex | Series A | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2003 | Venture Round | 4 | $9.5M |
BankInvest Equity Resources Group HealthCap Liftaeknisjodurinn HF BankInvest Equity Resources Group HealthCap Liftaeknisjodurinn HF |
8/2011 | Seed Round | $600k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|